A major challenge for mammalian hosts is to maintain symbiotic relationships with the vast bacterial communities that colonize the intestines. The intestinal epithelium is the primary barrier between the intestinal microbiota and internal host tissues, yet little is known about how epithelial cells control bacterial interactions with the mucosal surface and limit microbial penetration of the intestinal barrier. Filling this knowledge gap is crucial, as many gastrointestinal diseases of humans originate with pathogenic invasions of the intestinal epithelium, or involve dysregulated interactions between the commensal microbiota and epithelial cells. In the previous project period, we showed that intestinal epithelil cell autophagy limits tissue invasion by opportunistically invasive commensals and the invasive intestinal pathogen, Salmonella typhimurium. We found that autophagy activation by S. typhimurium requires the innate immune signaling adaptor MyD88, and is regulated by interactions between the anti-autophagy factor BCL2 and the essential autophagy protein Beclin 1. Our initial findings thus identify autophagy as an important epithelial cell-autonomous mechanism of antibacterial defense and indicate that epithelial autophagy activation is tightly regulated. During the next project period, we propose to build upon these findings to gain a deeper understanding of how antibacterial autophagy is regulated in the intestinal epithelium, and to elucidate the physiological significance of epithelial autophagy for maintaining homeostasis with the microbiota.
In Aim 1, we will use in vivo mouse models to further delineate the role of BCL2 in regulating antibacterial autophagy in the intestinal epithelium.
In Aim 2, we will use in vivo approaches to determine how MyD88 regulates antibacterial autophagy in intestinal epithelial cells.
In Aim 3, we will use mice harboring epithelial cell-specific autophag defects to test the hypothesis that autophagy promotes the clearance of opportunistically-invasive commensal bacteria. These studies will significantly advance our understanding of how intestinal epithelial cells promote homeostasis with the diverse bacterial community in the intestine. Further, our findings should suggest novel strategies for enhancing intestinal epithelia cell autophagy to protect against intestinal infections and inflammatory diseases.

Public Health Relevance

Humans harbor 100 trillion bacteria that make important contributions to health, but can invade host tissues and cause diseases such as inflammatory bowel disease and bacteremia. This proposal will explore how the cellular process of autophagy is regulated in intestinal epithelial cells and how epithelial autophagy promotes the clearance of bacteria that invade the intestinal barrier. Our findings should yield novel strategies for enhancing intestinal epithelial cell autophagy to protect against intestinal infections and inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK070855-10
Application #
8696519
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Perrin, Peter J
Project Start
2005-06-01
Project End
2019-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
10
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Choi, Jin Huk; Wang, Kuan-Wen; Zhang, Duanwu et al. (2017) IgD class switching is initiated by microbiota and limited to mucosa-associated lymphoid tissue in mice. Proc Natl Acad Sci U S A 114:E1196-E1204
Bel, Shai; Pendse, Mihir; Wang, Yuhao et al. (2017) Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine. Science 357:1047-1052
Spiga, Luisella; Winter, Maria G; Furtado de Carvalho, Tatiane et al. (2017) An Oxidative Central Metabolism Enables Salmonella to Utilize Microbiota-Derived Succinate. Cell Host Microbe 22:291-301.e6
Wang, Yuhao; Kuang, Zheng; Yu, Xiaofei et al. (2017) The intestinal microbiota regulates body composition through NFIL3 and the circadian clock. Science 357:912-916
Hughes, Elizabeth R; Winter, Maria G; Duerkop, Breck A et al. (2017) Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis. Cell Host Microbe 21:208-219
McAleer, Jeremy P; Nguyen, Nikki L H; Chen, Kong et al. (2016) Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome. J Immunol 197:97-107
Wang, Lirui; Fouts, Derrick E; Stärkel, Peter et al. (2016) Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. Cell Host Microbe 19:227-39
Duerkop, Breck A; Huo, Wenwen; Bhardwaj, Pooja et al. (2016) Molecular Basis for Lytic Bacteriophage Resistance in Enterococci. MBio 7:
Fan, Di; Coughlin, Laura A; Neubauer, Megan M et al. (2015) Activation of HIF-1? and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med 21:808-14
Hu, Shuiqing; Peng, Lan; Kwak, Youn-Tae et al. (2015) The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep 13:1922-36

Showing the most recent 10 out of 39 publications